COVID 19
NIH ANNOUNCEMENTS
|
|
NIH
|
04/13/2020 (Release Date)
|
COVID-19
|
|
|
NA
|
COVID-19
|
|
Columbia University Herbert Irving Comprehensive Cancer Center; https://cancer.columbia.edu/
|
NA, please see individual funding opportunities
|
COVID-19
|
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development
|
NICHD understands that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.; Training grant applications submitted to the Request for Applications RFA-HD-21-014(link is external and opens in a new window) with a due date of May 27, 2020 will be accepted as late applications through 5 PM local time June 30, 2020.; Institutions need not request advance permission to submit late due to this declared emergency and a cover letter referencing this Notice may be submitted but is not required.; Please note that we anticipate, but cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021); 06/30/2020
|
COVID-19
|
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development
|
It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215(link is external and opens in a new window) has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 06/29/2020 (New Due Date)
|
COVID-19
|
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development
|
NICHD understands that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.; Training grant applications submitted to the Request for Applications RFA-HD-21-014(link is external and opens in a new window) with a due date of May 27, 2020 will be accepted as late applications through 5 PM local time June 30, 2020.; Institutions need not request advance permission to submit late due to this declared emergency and a cover letter referencing this Notice may be submitted but is not required.; Please note that we anticipate, but cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021); 06/30/2020
|
COVID-19
|
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development
|
It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215(link is external and opens in a new window) has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 06/29/2020 (New Due Date)
|
COVID-19
|
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development
|
NICHD understands that the emergency declaration related to Coronavirus Disease 2019 (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner.; Training grant applications submitted to the Request for Applications RFA-HD-21-014(link is external and opens in a new window) with a due date of May 27, 2020 will be accepted as late applications through 5 PM local time June 30, 2020.; Institutions need not request advance permission to submit late due to this declared emergency and a cover letter referencing this Notice may be submitted but is not required.; Please note that we anticipate, but cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021); 06/30/2020
|
COVID-19
|
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development
|
It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215(link is external and opens in a new window) has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 06/29/2020 (New Due Date)
|
COVID-19
FOUNDATION FUNDING
MATERNAL AND CHILD HEALTH
|
|
Ferring Pharmaceuticals
|
Ferring COVID-19 Investigational Grants will be awarded within 14 days of receipt from 15th April – 31st October 2020.; 10/31/2020
|
COVID-19
FOUNDATION FUNDING
|
|
|
Open
|
COVID-19
HIGH PERFORMANCE COMPUTING
|
SRCPAC Major players offering Access to High Performance Computing for COVID-19 Research
|
|
|
COVID-19
|
|
|
NA; This webpage will continue to be updated frequently as new information is received.
|
COVID-19
BIG DATA
|
|
|
Ongoing
|
COVID-19
|
|
|
NA
|
COVID-19
WITHDRAWN DUE TO COVID-19 PANDEMIC
|
|
|
Due to the Covid-19 pandemic, the 2020 Translational grant (adult cancer types) Request For Applications (RFA), has been withdrawn, effective immediately
|
COVID-19
WEEKLY HIGHLIGHT
RETURNING TO CAMPUS
|
|
Mailman School
|
NA; page updated regularly
|
COVID-19
LATE APPLICATION POLICY
|
|
National Cancer Institute
|
|
COVID-19
|
|
National Center for Advancing Translational Sciences
|
See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; ; 03/10/2023 (Expiration)
|
COVID-19
|
|
|
Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates. ; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 01/25/2022 (Expiration, PA-18-935)
|
COVID-19
|
|
National Center for Complementary and Integrative Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism
|
Due dates may vary by awarding IC. See the awarding IC's web site for any applicable Application Due Dates
|
COVID-19
|
|
National Heart, Lung, and Blood Institute
|
NA
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
Applications will be accepted on a rolling basis, beginning on 04/30/2020; 04/30/2021 (Expiration)
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
Applications will be accepted on a rolling basis, beginning on 04/30/2020; 04/30/2021 (Expiration)
|
COVID-19
LATE APPLICATION POLICY
|
|
National Institute of Allergy and Infectious Diseases
|
[1] Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) RFA-AI-20-019(link is external and opens in a new window) ; 06/15/2020 (Application Deadline); 06/29/2020 (Late applications accepted until this date) ; [2] Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional) RFA-AI-19-073(link is external and opens in a new window); 06/19/2020 (Application Deadline); 07/06/2020 (Late applications accepted until this date); [3] Childhood Asthma in Urban Settings Clinical Research Network- Leadership Center (UM1 Clinical Trial Required); RFA-AI-19-074(link is external and opens in a new window); 06/19/2020 (Application Deadline); 07/06/2020 (Late applications accepted until this date); [4] Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed); RFA-AI-20-028(link is external and opens in a new window)
06/29/2020 (Application Deadline); 07/13/2020 (Late applications accepted until this date)
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
Applications for this limited competition FOA will be accepted on a rolling basis, beginning 07/13/2020; 07/08/2021 (Expiration)
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
Applications will be accepted on a rolling basis, beginning on 04/30/2020; 08/14/2020 (Revised Expiration Date); After this date, applicants are encouraged to consider applying to PA-19-056(link is external and opens in a new window), NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
Applications for this limited competition FOA will be accepted on a rolling basis, beginning 07/13/2020; 07/08/2021 (Expiration)
|
COVID-19
|
|
National Institute of Biomedical Imaging and Bioengineering
|
It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity Announcement PAR-19-215(link is external and opens in a new window) has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 07/29/2020 (Extended Deadline); 05/29/2021 (Expiration)
|
COVID-19
|
|
National Institute of Dental and Craniofacial Research; Office of Research on Women's Health
|
Please see piecemeal related announcements
|
COVID-19
|
|
National Institute of Environmental Health Sciences
|
NA
|
COVID-19
|
|
National Institute of General Medical Sciences
|
NA, please see Guidance
|
COVID-19
EMERGENCY COMPETITIVE REVISION TO EXISTING NIH AWARDS
|
|
National Institute of Mental Health
|
See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [For PA-20-135]
|
COVID-19
K-AWARDS
|
|
National Institute of Neurological Disorders and Stroke
|
NINDS understands that COVID-19 has caused a major disruption in the ability of many individuals to make progress on their research. Though subject to future updates, NINDS now will provide at least a 2-receipt cycle extension (roughly 8 additional months) of eligibility for individuals whose eligibility to apply for the K22, under normal eligibility rules (including resubmission policy as defined in NOT-OD-18-197(link is external and opens in a new window)), is expiring between June/July 2020 and February/March 2021 (inclusive of these dates). In addition, those who normally would have been eligible to apply for the June/July 2021 receipt date will have a 1-receipt cycle (roughly 4 months) extension
|
COVID-19
EMERGENCY COMPETITIVE REVISION TO EXISTING NIH AWARDS
|
|
National Institute of Nursing Research
|
See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [For PA-20-135]
|
COVID-19
|
|
National Institute on Aging
|
See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [PA-20-135]
|
COVID-19
|
|
National Institute on Deafness and Other Communication Disorders
|
Please see deadlines for piecemeal Supplements, this Notice does not affect their due dates
|
COVID-19
EMERGENCY COMPETITIVE REVISION TO EXISTING NIH AWARDS
|
|
National Library of Medicine
|
See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.; 03/10/2023 (Expiration) [For PA-20-135]
|
COVID-19
NSF
|
|
National Science Foundation
|
Please see piecemeal / individual opportunities
|
COVID-19
|
|
NIH
|
please see piecemeal opportunities which are also listed separately in this week’s Newsletter
|
COVID-19
|
|
NIH Office of Behavioral and Social Sciences Research
|
See piecemeal OBSSR_Relevant NOSIs
|
COVID-19
T32S
LATE APPLICATION POLICY
|
|
|
Training grant applications submitted to the Parent Funding Opportunity Announcements PA-20-142 and PA-20-162 with a due date of May 25 will be accepted through June 30, 2020.; Please note that we anticipate, [SPA Caveat] we cannot guarantee, that all late applications submitted by June 30, 2020 will be reviewed in the council round to which they were submitted (e.g. January 2021).
|
COVID-19
FOUNDATION FUNDING
|
|
Pfizer
|
To facilitate a rapid response, application reviews and approvals will be done on a rolling basis. Although the RFP application window is open for 4 weeks, organizations are encouraged to apply as soon as possible. We anticipate a high volume of applications and will continue to award grants until the budget is depleted, in which case the RFP will close before the listed closing date; 05/20/2020 (RFP Start Date); 06/17/2020 (Application closing date)
|
COVID-19
FOUNDATION FUNDING
|
07/06/2020 (Webinar); 08/05/2020 (Application)
|
Robert Wood Johnson Foundation
|
|
COVID-19
NSF
|
|
NSF
|
03/04/2020 (Release Date)
|
COVID-19
COMMENTARY
RWJF
|
|
Commentary, RWJF President, Washington Post
|
Published 03/05/2020
|
COVID-19
NIH ANNOUNCEMENTS
|
|
|
03/10/2020 (Release Date)
|
COVID-19
COGR
|
|
|
NA, 03/12/2020 (update, Release Date)
|
COVID-19
|
|
National Institutes of Health
|
03/16/2020 (Release Date)
|
COVID-19
|
|
|
03/16/2020 (Release Date)
|
COVID-19
NIH ANNOUNCEMENTS
|
|
NIH
|
NA 03/17/2020 (Last updated)
|
COVID-19
|
|
Research Resources
|
03/18/2020 (Transmission Date)
|
COVID-19
OMB MEMORANDUM
|
|
Executive Office of the President Office of Management and Budget
|
03/19/2020 (Release Date)
|
COVID-19
|
|
Research Resources
|
R2eport 03/20/2020 Newsletter Preamble
|
COVID-19
|
|
Research Resources
|
03/20/2020 (Release Date)
|
COVID-19
|
|
Research Resource
|
03/23/2020 (Transmission Date)
|
COVID-19
CDC BAA
|
|
CDC
|
03/25/2020
|
COVID-19
NSF
SMALL BUSINESS
|
|
|
03/25/2020 (Release Date); please see piecemeal opportunities
|
COVID-19
|
|
|
03/26/2020 (Release Date)
|
COVID-19
|
|
|
03/26/2020 (Release Date)
|
COVID-19
|
|
Food and Drug Administration
|
03/26/2020 (Release Date)
|
COVID-19
NIH LATE APPLICATION POLICY AND ACCOMPANYING VIDEO
|
NIH Update: Responding to Frequent Questions on Flexibilities Related to NIH Funding and COVID-19
|
NIH; Office of Extramural Research
|
03/26/2020 (Release Date) ; Please read the notice in its entirety. Grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020
|
COVID-19
SPA
|
We are currently assessing a number of recently released sponsor FAQs. We will be updating a number of FAQs on our website shortly. Recently released sponsor FAQs include:
Please continue to email questions to COVID19_research@columbia.edu(link sends e-mail); we will make sure your questions are routed to the right person so you receive a timely answer. Thank you.
Sincerely,
The Offices of the Executive Vice President for Research
|
SPA
|
NA, 03/27/2020 (Release Day)
|
COVID-19
SPA
|
|
SPA
|
NA, 03/27/2020 (Release Day)
|
COVID-19
COLUMBIA UNIVERSITY BIOBANK UPDATE
|
|
|
NA; The Columbia University Biobank (CUB) launched in April 2020 to advance our understanding of COVID-19 and its devastating clinical consequences has issued a CUB Update [06.17.2020](link is external and opens in a new window) and encourages you to apply to use these research resources through the CUB website
|
COVID-19
SPA ANNOUNCEMENT: COVID-19 FUNDING OPPORTUNITIES AND NEW WEBSITE
|
Resources to get Covid Funding Opportunities:
COVID-19 Funding Opportunities and New Website
|
Columbia Research/SPA
|
NA, Distributed 04/03/2020
|
COVID-19
AMERICAN HEART ASSOCIATION
|
|
|
04/06/2020
|
COVID-19
NIH NOTICES
|
|
|
NOT-AI-20-030 is going to expire as of 4/8/2020
|
COVID-19
|
|
CU University Life
|
04/13/2020 (Event Date)
|
COVID-19
NIH ANNOUNCEMENTS
|
|
NIH
|
04/13/2020 (Release Date)
|
COVID-19
NIH EXTRAMURAL NEXUS
|
|
|
04/15/2020 (Release Date)
|
COVID-19
PILOT
|
|
HICCC
|
04/17/2020
|
COVID-19
NIH EXTRAMURAL NEXUS
|
|
|
04/21/2020 (Release Date)
|
COVID-19
|
|
National Institute of Environmental Health Sciences
|
04/24/2020 (First Available Due Date); 04/25/2020
|
COVID-19
|
|
National Institute of Environmental Health Sciences
|
04/24/2020 (Frist Available Due Date); 04/25/2020 (Expiration)
|
COVID-19
|
|
National Cancer Institute
|
04/28/2020 (Release Date); For the duration of the present crisis
|
COVID-19
|
|
|
04/30/2020
|
COVID-19
WEBINAR
|
|
The Heilbrunn Department of Population and Family Health; Program on Forced Migration and Health (PopFam Dept)
|
04/30/2020, 9:00 AM – 11:30 AM (Webinar Date and time)
|
COVID-19
ENVIRONMENTAL
|
|
NIH; NIEHS
|
05/01/2020 (First Available Due Date); 05/01/2020 (Expiration Date)
|
COVID-19
|
|
National Institute of General Medical Sciences
|
05/05/2020 (First Available Due Date); 05/06/2020 (Expiration Date)
|
COVID-19
|
|
|
05/08/2020
|
COVID-19
SPONSORED PROJECTS ADMINISTRATION TOWN HALL
|
|
SPA
|
05/08/2020, 10AM – 11AM
|
COVID-19
|
|
National Institute of Dental and Craniofacial Research
|
05/13/2020 (Release Date)
|
COVID-19
FOUNDATION FUNDING
|
|
|
05/15/2020
|
COVID-19
|
|
National Human Genome Research Institute
|
04/03/2020 (First Available Due Date); 05/16/2020 (Expiration Date)
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
05/19/2020 (Expiration [Rescinded Date])
|
COVID-19
AMERICAN DIABETES ASSOCIATION
|
|
American Diabetes Association
|
05/22/2020
|
COVID-19
T32 TRAINING GRANTS
|
|
NIH; NIEHS
|
05/25/2020 (for Research Training Grant, Fellowship, and Career Development Award Applications for Applications Due on or After May 25, 2020); By way of this Notice, the National Institutes of Health and the Agency for Healthcare Research and Quality are reminding the biomedical and health services research communities of changes to forms and instructions for research training grant, fellowship, and career development award applications for due dates on or after May 25, 2020
|
COVID-19
PCORI
|
|
|
05/26/2020
|
COVID-19
|
|
National Cancer Institute
|
05/26/2020 (Response Date)
|
COVID-19
|
|
Agency for Healthcare Research and Quality
|
05/29/2020; 06/01/2020 (Expiration)
|
COVID-19
|
|
Agency for Healthcare Research and Quality
|
04/29/2020; 06/01/2020 (Expiration)
|
COVID-19
|
|
Agency for Healthcare Research and Quality
|
05/29/2020; 06/01/2020 (Expiration)
|
COVID-19
|
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
06/01/2020 (First Available Due Date); 06/02/2020 (Expiration)
|
COVID-19
|
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
06/01/2020 (First Available Due Date); 06/02/2020 (Expiration Date)
|
COVID-19
|
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
06/01/2020 (First Available Due Date); 06/02/2020 (Expiration)
|
COVID-19
|
|
National Institute on Deafness and Other Communication Disorders
|
04/07/2020 (First Available Due Date); 06/02/2020 (Expiration)
|
COVID-19
|
|
National Library of Medicine
|
06/01/2020 (First Available Due Date); 06/02/2020 (Expiration Date)
|
COVID-19
|
|
National Library of Medicine
|
06/01/2020 (First Available Due Date); 06/02/2020 (Expiration Date)
|
COVID-19
|
|
National Institute of Biomedical Imaging and Bioengineering
|
06/05/2020 (First Available Due Date); 06/05/2020 (Expiration Date)
|
COVID-19
BIG DATA
|
|
|
06/08/2020
|
COVID-19
|
|
National Institutes of Health
|
06/10/2020 (Release Date, this is a NOI, Notice of Information)
|
COVID-19
|
|
Agency for Healthcare Research and Quality
|
06/15/2020; 06/16/2020 (Expiration)
|
COVID-19
|
|
National Cancer Institute; National Institute of Allergy and Infectious Diseases
|
06/18/2020 (Application Webinar for RFA-CA-20-038 and RFA-CA-20-039)
|
COVID-19
|
|
National Institute of General Medical Sciences
|
06/18/2020 (First Available Due Date); 06/19/2020 (Expiration Date)
|
COVID-19
|
|
Office of Strategic Coordination (Common Fund)
|
04/15/2020 (First Available Due Date) 06/20/2020 (Expiration Date)
|
COVID-19
|
|
National Institutes of Health
|
06/22/2020 (First Available Due Date); 06/23/2020 (Expiration Date)
|
COVID-19
NIH DIRECTORS AWARDS
WEBINARS
|
|
Office of Strategic Coordination (Common Fund)
|
Submit your questions for the 06.25.2020 Webinar for the NIH Director’s New Innovator Award by 11:59 PM local time on Monday, June 22, 2020, to NewInnovatorAwards@mail.nih.gov(link sends e-mail).; Submit your questions for the 06.26.2020 Webinar for the NIH Director’s Pioneer Award by 11:59 PM local time on Tuesday, June 23, 2020, to PioneerAwards@mail.nih.gov(link sends e-mail) ; Submit your questions for the 06.29.2020 Webinar for the NIH Director’s Early Independence Award and the NIH Director’s Emergency Early Independence Award by 11:59 PM local time on Thursday, June 25, 2020, to EarlyIndependence@od.nih.gov(link sends e-mail); Submit your questions for the 06.29.2020 Webinar for the NIH Director’s Transformative Research Award and the NIH Director’s Emergency Transformative Research Award by 11:59 PM local time on Thursday, June 25, 2020, to Transformative_Awards@mail.nih.gov(link sends e-mail)
|
COVID-19
|
|
National Cancer Institute
|
04/14/2020 (First Available Due Date); 06/26/2020 (Expiration)
|
COVID-19
|
|
National Cancer Institute
|
04/14/2020 (First Available Due Date); 06/26/2020 (Expiration)
|
COVID-19
|
|
National Cancer Institute
|
04/14/2020 (First Available Due Date); 06/26/2020 (Expiration)
|
COVID-19
|
|
|
06/28/2020
|
COVID-19
|
|
National Institute of Biomedical Imaging and Bioengineering
It is anticipated that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect many NIH applicants' ability to submit applications in a timely manner. Hence, the May 28, 2020 due date for Funding Opportunity
|
Announcement PAR-19-215(link is external and opens in a new window) has been changed to June 29, 2020 by 5:00 PM local time of applicant organization.; 07/29/2020 (Extended Deadline); 05/29/2021 (Expiration)
|
COVID-19
LATE APPLICATION POLICY
|
|
National Cancer Institute
|
06/30/2020
|
COVID-19
UNDERSERVED POPULATIONS
|
|
|
07/2020 (July, 2020; First Estimated Application Due Date)
|
COVID-19
VICE DEAN’S TOWN HALL
|
|
Vice Deans of Finance and Administration and Research Strategy and Innovation
|
06/24/2020 (Town Hall); 07/01/2020 (Message)
|
COVID-19
|
[Added: "Competitive revision applications to this NOSI may not propose new foreign components and may not request additional funding for existing foreign components”]
|
National Institutes of Health
|
06/30/2020 (Release Date); 07/08/2020 (First Available Due Date); 09/09/2020 (Expiration) [NOT-OD-20-119, NOT-OD-20-120]; 08/07/2020 (First Available Due Date); 08/08/2020 (Expiration) [NOT-OD-20-121]
|
COVID-19
|
|
NIH
|
NA, 07/08/2020 (Release Date)
|
COVID-19
|
|
NIH
|
NA, 07/08/2020 (Release Date)
|
COVID-19
NIH ANNOUNCEMENTS
|
|
SPA/NIH
|
NIH issued guidance today (07/08/2020) related to preparing proposals for the May 2021 Council round beginning with applications submitted for the September 25, 2020 due date (see Review and Award Cycles(link is external and opens in a new window))
|
COVID-19
NIH ANNOUNCEMENTS
|
|
SPA/NIH
|
NIH issued guidance today (07/08/2020) related to preparing proposals for the May 2021 Council round beginning with applications submitted for the September 25, 2020 due date (see Review and Award Cycles(link is external and opens in a new window))
|
COVID-19
NIH ANNOUNCEMENTS
|
|
SPA/NIH
|
NIH issued guidance today (07/08/2020) related to preparing proposals for the May 2021 Council round beginning with applications submitted for the September 25, 2020 due date (see Review and Award Cycles(link is external and opens in a new window))
|
COVID-19
FOUNDATION FUNDING
DIVERSITY
|
|
CHEST Foundation and American Thoracic Society
|
07/17/2020
|
COVID-19
FOUNDATION FUNDING
|
|
|
07/17/2020
|
COVID-19
FOUNDATION FUNDING
|
|
|
07/17/2020
|
COVID-19
FOUNDATION FUNDING
|
|
Jedi Foundation
|
07/17/2020
|
COVID-19
|
|
National Institute of Mental Health; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention
|
07/20/2020 (First Estimated Application Due Date)
|
COVID-19
|
|
|
07/21/2020 (1PM, Webinar)
|
COVID-19
|
|
National Institute on Minority Health and Health Disparities; National Center for Complementary and Integrative Health; National Institute on Aging; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
07/22/2020 (First Estimated Due Dates)
|
COVID-19
|
|
National Cancer Institute; National Institute of Allergy and Infectious Diseases
|
07/22/2020; 07/23/2020 (Expiration)
|
COVID-19
|
|
National Cancer Institute; National Institute of Allergy and Infectious Diseases
|
07/22/2020; 07/23/2020 (Expiration)
|
COVID-19
|
|
|
07/22/2020 (Application); 07/23/2020 (Expiration)
|
COVID-19
FOUNDATION FUNDING
|
|
|
07/31/2020
|
COVID-19
FOUNDATION FUNDING
|
|
|
08/03/2020
|
COVID-19
LIMITED SUBMISSION
|
|
|
07/09/2020 (Internal, Limited Submission Deadline); 08/04/2020 (NIH Letter of Intent Deadline); 09/04/2020 (NIH Proposal Deadline)
|
COVID-19
FOUNDATION FUNDING
|
|
|
08/05/2020
|
COVID-19
FOUNDATION FUNDING
|
|
Robert Wood Johnson Foundation
|
07/06/2020 (Webinar); 08/05/2020 (Application)
|
COVID-19
CANCER
K-AWARDS
|
|
National Cancer Institute
|
Late applications will be accepted through 5:00 PM local time July 1, 2020, for PAR-19-242 "Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)" No late applications submitted after July 1, 2020, will be considered.; 07/01/2020 (Late Application Deadline); 06/18/2021 (Expiration)
|
COVID-19
CANCER
K-AWARDS
|
|
National Cancer Institute
|
Late applications will be accepted through 5:00 PM local time July 1, 2020, for PAR-19-242 "Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)" No late applications submitted after July 1, 2020, will be considered.; 07/01/2020 (Late Application Deadline); 06/18/2021 (Expiration)
|
COVID-19
LATE APPLICATION POLICY
|
|
National Institute on Aging
|
Late applications will be accepted by 5:00 PM local time up to two weeks after the application due date for the NIA-specific FOAs listed below. Institutions do not need to request advance permission. While a cover letter may be provided, it is not required to take advantage of this flexibility; please see announcement NOT-AG-20-033(link is external and opens in a new window)
|
COVID-19
|
|
National Institutes of Health
|
08/07/2020; 08/08/2020 (Expiration) [for RFA-OD-20-013]
|
COVID-19
|
|
|
08/07/2020; 08/08/2020 (Expiration)
|
COVID-19
BIG DATA
|
|
National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
08/07/2020; 08/08/2020 (Expiration)
|
COVID-19
|
|
National Institutes of Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
08/07/2020 (First Available Due Date); 08/08/2020 (Expiration Date)
|
COVID-19
LIMITED COMPETITION
|
|
NIH
|
08/07/2020 (First Available Due Date); 08/08/2020 (Expiration)
|
COVID-19
LIMITED SUBMISSION
|
|
|
07/08/2020 (Internal Deadline); 08/13/2020 (Sponsor Deadline);
|
COVID-19
FOUNDATION FUNDING
|
|
Anonymous Donor via Columbia Engineering
|
08/14/2020
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
|
COVID-19
CANCER
|
|
|
07/06/2020 (First Available Due Date); 08/15/2020 (Expiration Date)
|
COVID-19
|
|
|
05/22/2020 (First Available Due Date); 08/18/2020 (Expiration Date)
|
COVID-19
FOUNDATION FUNDING
|
|
|
08/31/2020
|
COVID-19
NIH DIRECTOR’S AWARDS PROGRAM
|
|
Office of Strategic Coordination (Common Fund)
|
09/04/2020; 09/05/2020 (Expiration)
|
COVID-19
|
|
|
07/08/2020 (First Available Due Date); 09/09/2020 (Expiration)
|
COVID-19
|
|
National Institutes of Health
|
07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
|
COVID-19
|
|
National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
|
COVID-19
|
|
National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
|
COVID-19
|
|
National Institutes of Health; John E. Fogarty International Center; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Eye Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of General Medical Sciences; National Institute of Mental Health; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; National Institute of Nursing Research; National Library of Medicine; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
07/08/2020 (First Available Due Date); 09/09/2020 (Expiration Date)
|
COVID-19
|
|
NIH
|
08/07/2020; 09/09/2020 (Expiration)
|
COVID-19
|
|
NIH
|
07/08/2020 (First Available Due Date); 09/09/2020 (Expiration)
|
COVID-19
|
|
|
07/08/2020 (First Available Due Date); 08/07/2020; 09/09/2020 (Expiration)
|
COVID-19
FOUNDATION FUNDING
CYSTIC FIBROSIS
|
|
|
07/17/2020 (Letter of Intent); 10/01/2020 (Full Application)
|
COVID-19
NIH DIRECTOR’S AWARDS PROGRAM
|
|
Office of Strategic Coordination (Common Fund)
|
09/30/2020; 10/01/2020 (Expiration)
|
COVID-19
|
|
National Heart, Lung, and Blood Institute
|
03/17/2020 (First Available Due Date); 10/06/2020 (Expiration)
|
COVID-19
|
|
National Center for Advancing Translational Sciences
|
06/05/2020 (Frist Available Due Date); 10/17/2020 (Expiration)
|
COVID-19
|
|
National Institute on Aging
|
07/01/2020; 08/03/2020; 09/01/2020; 10/01/2020; 11/02/2020; 12/01/20220; 01/04/2021; 02/01/2021; 02/02/2021 (Expiration)
|
COVID-19
|
|
National Institute of Biomedical Imaging and Bioengineering
|
04/02/2020 (First Available Due Date); 11/10/2020 (Expiration Date)
|
COVID-19
TRANSLATIONAL
|
|
National Center for Advancing Translational Sciences
|
05/04/2020 (First Available Due Date); 11/11/2020 (Expiration Date)
|
COVID-19
|
|
National Center for Advancing Translational Sciences
|
06/12/2020 (First Available Due Date); 11/11/2020 (Expiration Date)
|
COVID-19
HEALTHCARE DISPARITIES
|
|
National Institute on Minority Health and Health Disparities; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of Mental Health; National Institute of Nursing Research; Office of Disease Prevention; Office of Research on Women's Health
|
08/28/2020; 12/01/2020; 12/02/2020 (Expiration)
|
COVID-19
|
|
NIH
|
08/28/2020; 12/01/2020; 12/02/2020 (Expiration)
|
COVID-19
HEALTHCARE DISPARITIES
|
|
NIH
|
08/28/2020; 12/01/2020; 12/02/2020 (Expiration)
|
COVID-19
HEALTHCARE DISPARITIES
|
|
NIH
|
On a rolling basis through 12/15/2020; 12/16/2020 (Expiration); 06/10/2020 (First Available Due Date); 12/30/2020 (Expiration Date)
|
COVID-19
|
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
12/16/2020; 12/17/2020 (Expiration)
|
COVID-19
|
|
National Institute of Mental Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
06/10/2020 (First Available Due Date); 12/30/2020 (Expiration Date)
|
COVID-19
|
|
National Institute on Minority Health and Health Disparities; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute of Mental Health; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
06/10/2020 (First Available Due Date); 12/30/2020 (Expiration Date)
|
COVID-19
|
|
|
For applications submitted for the January 2021 council (beginning with applications submitted for the May 25, 2020 due date for Fall 2020 review meetings), the NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.; The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting. Because applications for emergency competitive revisions and urgent competitive revisions undergo expedited review, post-submission materials will not be accepted for those applications.; All other materials listed in NOT-OD-19-083(link is external and opens in a new window) as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting.
|
COVID-19
|
|
|
03/25/2020 (First Available Due Date); 02/06/2021 (Expiration Date)
|
COVID-19
|
|
National Institute of Mental Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Eye Institute; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; Office of Behavioral and Social Sciences Research; Office of Disease Prevention; Office of Research on Women's Health
|
08/20/2020; 12/02/2020; 03/02/2021; 03/03/2021 (Expiration)
|
COVID-19
DIGITAL HEALTHCARE
|
|
NIH
|
08/20/2020; 12/02/2020; 03/02/2021; 03/03/2021 (Expiration)
|
COVID-19
SOCIAL CONNECTEDNESS AND ISOLATION
|
|
NIH
|
03/17/2021; 03/18/2021 (Expiration)
|
COVID-19
|
|
|
03/25/2020 (First Available Due Date); 03/25/2021 (Expiration Date)
|
COVID-19
|
|
National Institute of Biomedical Imaging and Bioengineering
|
04/05/2020 (First Available Due Date); 03/31/2021 (Expiration Date)
|
COVID-19
|
|
National Institute on Drug Abuse
|
03/19/2020 (First Available Due Date); 03/31/2021 (Expiration)
|
COVID-19
NOTICE OF SPECIAL INTEREST
|
|
|
03/19/2020 (First available due date); 03/31/2021 (Expiration)
|
COVID-19
|
|
|
03/19/2020 (First available due date); 03/31/2021 (Expiration)
|
COVID-19
BEHAVIORAL SCIENCES
SOCIAL SCIENCES
|
|
|
04/13/2020 (First Available Due Date); 04/01/2021 (Expiration)
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
04/05/2020 (First Available Due Date); 04/05/2021 (Expiration)
|
COVID-19
|
|
National Institute of Neurological Disorders and Stroke
|
05/01/2020 (First Available Due Date); 04/15/2021 (Expiration Date)
|
COVID-19
|
|
National Institute of Neurological Disorders and Stroke
|
05/01/2020 (First Available Due Date); 04/15/2021 (Expiration Date)
|
COVID-19
|
|
National Institute of Mental Health
|
03/27/2020 (First Available Due Date); 04/16/2021 (Expiration Date) NOT-MH-20-047; 04/06/2020 (First Available Due Date); 05/01/2021 (Expiration Date) NOT-AG-20-022
05/01/2020 (First Available Due Date); 05/01/2021 (Expiration Date) NOT-MD-20-019
|
COVID-19
|
|
National Institute of Mental Health; National Institute on Aging; National Institute on Alcohol Abuse and Alcoholism; National Institute on Minority Health and Health Disparities; Office of Disease Prevention
|
03/27/2020 (First Available Due Date); 04/16/2021 (Expiration Date)
|
COVID-19
|
|
National Institute on Alcohol Abuse and Alcoholism
|
05/15/2020 (First Available Due Date); 04/16/2021 (Expiration Date)
|
COVID-19
|
|
National Institute on Aging
|
04/06/2020 (First Available Due Date); 05/01/2021 (Expiration Date)
|
COVID-19
|
|
|
04/06/2020 (First Available Due Date); 05/01/2021 (Expiration)
|
COVID-19
HEALTHCARE DISPARITIES
|
|
National Institute on Minority Health and Health Disparities
|
05/01/2020 (First Available Due Date); 05/01/2021 (Expiration); applicants who apply before 07/15/2020 will be considered for funding during FY 2020); applicants who apply after 07/15/2020 will be considered for FY 2021 [for NOT-MD-20-019]
|
COVID-19
|
|
National Institute on Minority Health and Health Disparities; National Institute on Aging; National Institute of Mental Health
|
05/01/2020 (First Available Due Date); 05/01/2021 (Expiration Date)
|
COVID-19
|
|
National Institute of Environmental Health Sciences
|
05/01/2020 (First Available Due Date); 05/04/2021 (Expiration)
|
COVID-19
|
|
|
05/01/2020 (First Available Due Date); 05/04/2021 (Expiration Date)
|
COVID-19
|
|
|
05/01/2020 (First Available Due Date) 05/04/2021 (Expiration Date); [NOT-ES-20-015]; 07/22/2020 (First Estimated Application Due Date) [NOT-MD-20-023]
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
07/02/2020 (First Available Due Date); 07/02/2021 (Expiration Date)
|
COVID-19
|
|
National Center for Advancing Translational Sciences
|
05/04/2020 (First Available Due Date); 07/10/2021 (Expiration Date)
|
COVID-19
|
|
|
05/04/2020 (First Available Due Date); 07/10/2021 (Expiration)
|
COVID-19
DOWN SYNDROME
|
|
National Institutes of Health; National Center for Advancing Translational Sciences; National Center for Complementary and Integrative Health; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Environmental Health Sciences; National Institute on Minority Health and Health Disparities; National Institute of Neurological Disorders and Stroke; Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
|
07/13/2020 (First Available Due Date); 07/13/2021 (Expiration Date)
|
COVID-19
|
|
National Institute of Allergy and Infectious Diseases
|
06/16/2020 (First Available Due Date); 09/08/2021 (Expiration Date)
|
COVID-19
SUBSTANCE USE DISORDERS
|
|
National Institute on Drug Abuse; National Cancer Institute
|
06/08/2020; 10/06/2020; 02/08/2021; 06/08/2021; 10/08/2021; 10/09/2021 (Expiration)
|
COVID-19
|
|
|
04/03/2020 (Release Date); 01/25/2022 (Expiration) ; Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
|
COVID-19
|
|
|
04/02/2020 (Release Date): 01/25/2022 (Expiration) ; Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.; Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
|
COVID-19
|
|
National Center for Advancing Translational Sciences
|
05/15/2020 (First Available Due Date); 01/26/2022 (Expiration)
|
COVID-19
|
|
National Center for Advancing Translational Sciences
|
05/15/2020 (First Available Due Date); 01/26/2022 (Expiration Date)
|
COVID-19
|
|
National Library of Medicine
|
06/16/2020 (First Available Due Date); 06/17/2022 (Expiration Date)
|
COVID-19
|
|
National Institute on Deafness and Other Communication Disorders
|
10/05/2020 (First Available Due Date); 09/08/2022 (Expiration Date)
|
COVID-19
|
|
National Heart, Lung, and Blood Institute
|
05/01/2020 (First Available Due Date); 10/06/2022 (Expiration Date)
|
COVID-19
|
|
National Institute on Deafness and Other Communication Disorders
|
03/10/2023 (Expiration) [PA-20-135]
|
COVID-19
|
|
National Institute on Drug Abuse
|
03/10/2023 (Expiration) [PA-20-135]
|
COVID-19
|
|
Office of Research on Women's Health
|
03/10/2023 (Expiration) [PA-20-135]
|
COVID-19 OPPORTUNITIES CURATED IN PIVOT
|
Resources to access COVID-19 Funding Opportunities and New Website:
|
|
Please note that effective May 01, 2020 (05/01/2020) SPA will continue to support the funding opportunity database Pivot, and will no longer support InfoEd SPIN / SMARTS
|
COVID-19 RESEARCH AT COLUMBIA UPDATED FAQS AND LINKS
|
|
Research @ Columbia and Sponsored Projects Administration
|
NA
|
CRIMINAL JUSTICE SYSTEM
|
|
National Institute of Justice/Department of Justice
|
04/29/2020
|
DEDICATED CU WEBSITE, COVID-19: FAQS AND RESOURCES RELATING TO RESEARCH
|
|
|
NA
|
NEW DEDICATED CU WEBSITE, COVID-19: FAQS AND RESOURCES RELATING TO RESEARCH
|
Dear Mailman Investigators,
I want to remind everyone of the following site at Columbia that aggregates all of the COVID-19 related research news. This site is being updated on a regular basis.
Gary
Gary W. Miller, Ph.D.
Vice Dean for Research Strategy and Innovation
Professor, Department of Environmental Health Sciences
Columbia University Mailman School of Public Health
722 West 168th Street, Room 1411B, New York, NY 10032
|
|
NA
|
NIH ANNOUNCEMENTS
COVID-19
|
|
|
03/10/2020 (Release Date)
|
RESEARCH RESOURCES COVID-19 TRANSMISSION, 03/23/2020
|
|
Research Resources
|
Transmission Date 03/23/2020
|
SPA COVID TOWN HALL SUMMARY
|
|
Sponsored Projects Administration
|
05/08/2020 (Event Date)
|
